Letter: rising incidence and poor survival in patients with non-viral HCC - better HCC surveillance and treatment for alcohol-associated and non-alcohol fatty liver diseases are needed. Authors' reply.
Hidenori ToyodaKazuya KariyamaAtsushi HiraokaPublished in: Alimentary pharmacology & therapeutics (2023)